These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 3057844)

  • 1. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN; Kaplinsky E; Kirsten E; Guerrero J
    Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
    Naccarella F; Bracchetti D; Palmieri M; Cantelli I; Bertaccini P; Ambrosioni E
    Am Heart J; 1985 Apr; 109(4):833-40. PubMed ID: 3885700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the anti-arrhythmic effects of propafenone and aprindine in the treatment of refractory chronic ventricular arrhythmias. A randomized double-blind crossover study controlled with placebo].
    Purcaro A; Amici R; Ciampani N; Costantini C; Mocchegiani R; Pigini G
    G Ital Cardiol; 1983; 13(6):444-50. PubMed ID: 6357929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propafenone versus disopyramide: a double-blind randomized crossover trial in patients presenting chronic ventricular arrhythmias.
    Libersa C; Caron J; Pladys A; Beuscart R; Kacet S; Wajman A; Connell C; Dupuis B; Lekieffre J
    Clin Cardiol; 1987 Jul; 10(7):405-10. PubMed ID: 2440632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
    Zoble RG; Kirsten EB; Brewington J
    Clin Pharmacol Ther; 1989 May; 45(5):535-41. PubMed ID: 2721109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes.
    Salerno DM; Granrud G; Sharkey P; Asinger R; Hodges M
    Am J Cardiol; 1984 Jan; 53(1):77-83. PubMed ID: 6362387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of propafenone and disopyramide in the treatment of ventricular premature complexes: a randomized double blind crossover placebo controlled trial.
    Rabkin SW; Boroomand-Rashti K; McKinnon J; Rotem CE
    Can J Cardiol; 1987 Apr; 3(3):105-10. PubMed ID: 3297265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M; Salerno D; Granrud G
    Am J Cardiol; 1984 Nov; 54(9):45D-50D. PubMed ID: 6388303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
    Dinh HA; Murphy ML; Baker BJ; deSoyza N; Franciosa JA
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1520-4. PubMed ID: 3890510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
    Härtel G
    Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study.
    Jonason T; Ringqvist I; Bandh S; Nilsson G; Nilsson H; Lidell C; Bjerle P; Olofsson BO
    Acta Med Scand; 1988; 223(6):515-23. PubMed ID: 3291557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
    Zehender M; Hohnloser S; Geibel A; Furtwängler A; Olschewski M; Meinertz T; Just H
    Br Heart J; 1992 Jun; 67(6):491-7. PubMed ID: 1622701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cibenzoline for symptomatic ventricular arrhythmias: a prospective, randomized, double-blind, placebo controlled trial and a long term open label study.
    Lee MA; Fenster PE; Garcia ZM; Kipps JE; Huang SK
    Can J Cardiol; 1989 Sep; 5(6):295-8. PubMed ID: 2477130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia].
    Babuty D; Cosnay P; Rouesnel P; Bine-Scheck F; Arnaud R; Fauchier JP
    Ann Cardiol Angeiol (Paris); 1992 Apr; 41(4):225-34. PubMed ID: 1642441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
    Mastropasqua F; Totaro P; Massari F; Pitzalis MV; Rizzon P
    Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction.
    Touboul P; Moleur P; Mathieu MP; Vrancea F; Ferry S; Kirkorian G; Atallah G; Marchand A; Stahl C; Zoheir F
    Eur Heart J; 1988 Nov; 9(11):1188-93. PubMed ID: 3234410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.